(2006) Transcriptional profiling of Candida albicans in human blood. Microbe / ASM News 1, 76-80. (Review)
(2006) The vesicle transport protein Vac1p is required for virulence of Candida albicans. Microbiology 152(Pt 10), 3111-3121.
(2006) Two factor H-related proteins from the mouse: expression analysis and functional characterization. Immunogenetics 58(11), 883-893.
(2006) Infection-associated genes of Candida albicans. Future Microbiol 1(2), 209-218. (Review)
(2006) Candida and Candidosis today: where are we, and where to go? The Interdisciplinary Forum on Candidosis (IFOCAN) 2005, Göttingen (Germany), 23-25 September 2005. FEMS Yeast Res 6(8), 1290-1294. (Review)
(2006) The conversion efficiency of trans-11 and trans-12 18:1 by Delta9-desaturation differs in rats. J Nutr 136(5), 1209-1214.
(2006) Deletion of the gliP gene of Aspergillus fumigatus results in loss of gliotoxin production but has no effect on virulence of the fungus in a low-dose mouse infection model. Mol Microbiol 62(1), 292-302.
(2006) Influence of absorption enhancers on the pharmacokinetic properties of non-oral beta-lactam-cefpirom using the rabbit (Chinchilla) in vivo model. Int J Pharm 309(1-2), 67-70.
(2006) Comparison of susceptibility and transcription profile of the new antifungal Hassallidin A with caspofungin. Biochem Biophys Res Commun 349(2), 740-749.
(2006) Utilization of the embryonated egg for in vivo evaluation of the anti-influenza virus activity of neuraminidase inhibitors. Med Microbiol Immunol 195(2), 65-71.